Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Inappropriate sinus tachycardia overview

Introduction

Overview

Overview

Inappropriate sinus tachycardia is an uncommon form of supraventricular tachycardia (SVT).

Epidemiology and Demographics

Epidemiology and Demographics

The condition was first formally recognized as a veritable syndrome in 1979.

Pathophysiology

Pathophysiology

The mechanism of the arrhythmia primarily involves the sinus node and peri-nodal tissue[1] and does not require the AV node for maintenance. These patients have no apparent heart disease or other causes of sinus tachycardia. IST is thought to be due to abnormal autonomic control or dysautonomia. An autoimmune mechanism has been suggested as several studies have detected autoantibodies that activate beta adrenoreceptors in a portion of patients.[2][3]

References

References

  1. ↑ Sato, Toshiaki; Mitamura, Hideo; Murata, Mitsushige; Shinagawa, Kaori; Miyoshi, Shunichiro; Kanki, Hideaki; Takatsuki, Seiji; Soejima, Kyoko; Miyazaki, Toshihisa (2000). “Electrophysiologic findings of a patient with inappropriate sinus tachycardia cured by selective radiofrequency catheter ablation”. Journal of Electrocardiology. 33 (4): 381–6. doi:10.1054/jelc.2000.9648. PMID 11099363.
  2. ↑ Chiale, Pablo A.; Garro, Hugo A.; Schmidberg, Jorge; Sánchez, Rubén A.; Acunzo, Rafael S.; Lago, Manuel; Levy, Gabriela; Levin, Mariano (2006). “Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac β andrenergic receptors”. Heart Rhythm. 3 (10): 1182–6. doi:10.1016/j.hrthm.2006.06.011. PMID 17018348.
  3. ↑ Nattel, Stanley (2006). “Inappropriate sinus tachycardia and beta-receptor autoantibodies: A mechanistic breakthrough?”. Heart Rhythm. 3 (10): 1187–8. doi:10.1016/j.hrthm.2006.07.019. PMID 17018349.


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]